Camlin Announces Agreement to Sell Modular Spectroscopy and Hyperspectral Imaging Unit of Photonics Business to Clyde Hyperspectral Imaging & Technology Limited in Management Buy Out

UK, Release: 2nd April 2020.

Camlin, a privately owned technology company focused on critical infrastructure networks and optimisation, today announced the sale of its ‘Modular Spectroscopy and Hyperspectral Imaging Unit’ from its Photonics Division to Clyde Hyperspectral Imaging & Technology Limited.

Camlin’s portfolio primarily consists of business units which primarily focus on supplying devices, software and services to the Energy and Rail Networks globally. The sale is in line with Camlin’s concentration on these customers and industry sectors, allowing it to penetrate further into its core business segments.

Clyde Hyperspectral Imaging & Technology Limited was created specifically to strongly support worldwide customers in hyperspectral imaging and to bring to the market new instruments in optical spectroscopy and imaging.  With over 15 years direct hyperspectral imaging experience this management buy-out consolidates its work focussed upon spectral cameras, systems, software and the development of on-line hyperspectral machine vision systems.

Peter Cunningham, Chief Executive Officer (CEO) of Camlin, said
“We see this sale as a positive consolidation of our core assets and continuing strategy to focus on giving enhanced support and services to our Energy and Rail stakeholders.”

Ian Hunter, Managing Director of Camlin’s Photonics Division added,
Camlin will be continuing to work on its BioGas monitoring products and enhance its offer to the wider Gas segment to complement its already comprehensive Energy portfolio.”

Dr. John Gilchrist, Managing Director of ClydeHSI, said,
“we are delighted to being able to make this management buy-out and bring the next generation of optical spectroscopy products to market that solve real-life customer measurement problems.  Our experienced team are focussed on closely working with customers to provide the correct hardware, software and analysis solutions.  This management buy-out allows us to strengthen these areas and to focus the Company on hyper-spectral imaging solutions.”

The transaction completed on the 31st March 2020.
 
For further information:
Clyde:
Dr John R Gilchrist
[email protected]

Camlin:
Ian Hunter
[email protected]